Android app on Google Play

Grifols (GRFS) Completes Acquisition of Talecris Biotherapeutics

June 3, 2011 1:59 PM EDT Send to a Friend
Get Alerts GRFS Hot Sheet
Trade GRFS Now!
Join SI Premium – FREE
Grifols, S.A. (NASDAQ: GRFS) announced that on June 1, 2011, Grifols completed its acquisition of Talecris Biotherapeutics Holdings Corp. In partial consideration for their shares, Talecris shareholders received Grifols non-voting shares that trade in the U.S. as Grifols ADSs. These new Grifols ADSs are listed on the NASDAQ Stock Exchange under the symbol "GRFS."




You May Also Be Interested In


Related Categories

Corporate News, Mergers and Acquisitions

Add Your Comment